NCT05915208View on ClinicalTrials.gov

Histiocytic Disorder Follow-up Study

RecruitingOBSERVATIONAL
Enrollment

6,000

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2028

Conditions
HistiocytosisLangerhans Cell HistiocytosisErdheim-Chester DiseaseRosai Dorfman DiseaseXanthogranulomaMalignant Histiocytoses
Trial Locations (1)

35233

RECRUITING

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER